Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 2—February 2005
Research

Human Disease from Influenza A (H5N1), Thailand, 2004

Tawee Chotpitayasunondh*, Kumnuan Ungchusak†, Wanna Hanshaoworakul†, Supamit Chunsuthiwat†, Pathom Sawanpanyalert†, Rungruen Kijphati†, Sorasak Lochindarat*, Panida Srisan*, Pongsan Suwan†, Yutthasak Osotthanakorn†, Tanakorn Anantasetagoon†, Supornchai Kanjanawasri†, Sureeporn Tanupattarachai†, Jiranun Weerakul†, Ruangsri Chaiwirattana†, Monthira Maneerattanaporn†, Rapol Poolsavatkitikool†, Kulkunya Chokephaibulkit‡, Anucha Apisarnthanarak§, and Scott F. Dowell¶Comments to Author 
Author affiliations: *Queen Sirikit National Institute of Child Health, Bangkok, Thailand; †Ministry of Public Health, Nonthaburi, Thailand; ‡Siriraj Hospital, Bangkok, Thailand; §Thammasat University Hospital, Bangkok, Thailand; ¶International Emerging Infections Program, Nonthaburi, Thailand

Main Article

Figure 4

Timing of the clinical course and oseltamivir treatment for 4 patients who survived and 8 patients who died of human influenza A (H5N1) infection, Thailand, 2004.

Figure 4. Timing of the clinical course and oseltamivir treatment for 4 patients who survived and 8 patients who died of human influenza A (H5N1) infection, Thailand, 2004.

Main Article

Page created: April 28, 2011
Page updated: April 28, 2011
Page reviewed: April 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external